Hadassah

Hadassah and Australia Research Institute Sign MOU to Collaborate

Wednesday, Dec 6 2017

Prof. Chaim Lotan, head of Hadassah’s Heart Institute, and Diabetes Expert Prof. Jonathan Shaw of the Baker Heart and Diabetes Institute, display the Memorandum of Understanding signed between their respective medical institutions.

A Memorandum of Understanding (MOU) to cooperate on scientific research in the fields of cardiovascular and diabetes medicine was signed on August 31 between the Hadassah Medical Organization and the Baker Heart and Diabetes Research Institute in Melbourne, Australia.

The connection between Hadassah and Baker, an independent research institute that focuses on the diagnosis, prevention, and treatment of cardiovascular disease and diabetes, was forged about 18 months ago when Prof. Chaim Lotan, head of Hadassah’s Heart Institute, visited Baker while in Australia, working on a joint project with the University of Melbourne. Prof. Ronen Beeri, head of Hadassah’s Cardiovascular Research Center, and his colleagues organized an annual seminar for a group of Baker researchers visiting Israel, which included researchers from medical institutions throughout Israel. As a result, multiple research collaborations have been formed.

Hadassah is currently working on a collaborative research project investigating the pathophysiology of takotsubo cardiomyopathy. Known also as “broken heart syndrome,” or stress cardiomyopathy, the event mimics a heart attack, but there is no angiographic evidence of obstructive coronary artery disease or acute plaque rupture. The term, takotsubo is taken from the Japanese name for an octopus trap, because during the acute phase of the syndrome, the heart’s left ventricle bulges and takes on a balloon shape similar in appearance to this trap used by Japanese fishermen.

One joint diabetes research project underway between researchers from the Baker Institute and Hadassah is a study of the death of insulin-producing beta cells in the pancreas. Understanding this may lead to new ways of treating the disease.

Baker Diabetes Expert Prof. Jonathan Shaw, who is involved in this groundbreaking study, traveled to Jerusalem to sign the Memorandum of Understanding. He brings out: 'We have enjoyed a strong relationship with Hadassah Medical Center for several years and the signing of this Memorandum of Understanding formalizes this relationship.”

Another collaborative project is taking place in the endocrinology laboratories of Prof. Benjamin Glaser, head of Hadassah’s Department of Endocrinology. The project is focused on the genetics of diabetes. Last year, Prof. Glaser participated with more than 300 scientists from 22 countries in an international study, which revealed that most of the genetic risk for developing type 2 diabetes can be attributed to common, shared differences in the genetic code, each of which contributes a small amount to an individual’s risk of disease.

For over the last 15 years, Prof. Glaser has led the Middle East charge on type 2 diabetes and its genetics. “When we started working on this, almost two decades ago,” he relates, “we naively thought that we could find the genetic cause of diabetes by studying a thousand individuals using a few hundred genetic markers. We now know that we need to study hundreds of thousands of individuals, using millions of genetic markers, just to begin to understand the genetics of this common and devastating disease.”

Read more at http://www.hadassah.org/news-stories/genetic-links-to-diabetes.html

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

Tuesday, Jun 12 2018

Hadassah Ophthalmology Department Research Highlighted by JAMA

Thanking the Hadassah Medical Organization’s researchers for their ”excellent submission” to JAMA Ophthalmology regarding a multi-center international study of the variable effectiveness of treatment for neovascular age-related macular degeneration (nAMD), the editors explained that their article was one of just a few from 12 JAMA on-line journals to be highlighted in The JAMA Network Reader this weekend.

READ MORE ›
alt_text

Monday, Jun 11 2018

Ruth Radiano: Passionate New Director of Nursing at Hadassah Hospital Mount Scopus

Translating her passion and professionalism into action, Ruth Radiano, the new Director of Nursing at Hadassah Hospital Mount Scopus, brings a background of 26 years of nursing at Hadassah.

READ MORE ›
alt_text

Thursday, Jun 7 2018

Former NYC Mayor Giuliani Calls Hadassah Hospital a Blessing

Former New York City Mayor Rudy Giuliani and his partner Dr. Maria Ryan, CEO of Cottage Hospital in Woodsville, New Hampshire visited Hadassah Medical Organization in Jerusalem today to get an update on Hadassah’s management of terror events.

READ MORE ›
alt_text

Thursday, Jun 7 2018

Hadassah Researchers Develop Definitive Biomarker for Cardiac Muscle Death and Link it to Death from Sepsis

Hadassah Medical Organization researchers, in collaboration with colleagues at the Hadassah-Hebrew University School of Medicine, have developed a blood test which definitively detects death of cardiac muscle cells following an acute heart attack and in the case of sepsis.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More